Neutrophils provide a critical line of defense in immune responses to various pathogens, inflicting self-damage upon transition to a hyperactivated, procoagulant state. Recent work has highlighted proinflammatory neutrophil phenotypes contributing to lung injury and acute respiratory distress syndrome (ARDS) in patients with coronavirus disease 2019 (COVID-19). Here, we use state-of-the art mass spectrometry–based proteomics and transcriptomic and correlative analyses as well as functional in vitro and in vivo studies to dissect how neutrophils contribute to the progression to severe COVID-19. We identify a reinforcing loop of both systemic and neutrophil intrinsic IL-8 (CXCL8/IL-8) dysregulation, which initiates and perpetuates neutrophil-driven immunopathology. This positive feedback loop of systemic and neutrophil autocrine IL-8 production leads to an activated, prothrombotic neutrophil phenotype characterized by degranulation and neutrophil extracellular trap (NET) formation. In severe COVID-19, neutrophils directly initiate the coagulation and complement cascade, highlighting a link to the immunothrombotic state observed in these patients. Targeting the IL-8–CXCR-1/-2 axis interferes with this vicious cycle and attenuates neutrophil activation, degranulation, NETosis, and IL-8 release. Finally, we show that blocking IL-8–like signaling reduces severe acute respiratory distress syndrome of coronavirus 2 (SARS-CoV-2) spike protein–induced, human ACE2–dependent pulmonary microthrombosis in mice. In summary, our data provide comprehensive insights into the activation mechanisms of neutrophils in COVID-19 and uncover a self-sustaining neutrophil–IL-8 axis as a promising therapeutic target in severe SARS-CoV-2 infection.
Rainer Kaiser, Alexander Leunig, Kami Pekayvaz, Oliver Popp, Markus Joppich, Vivien Polewka, Raphael Escaig, Afra Anjum, Marie-Louise Hoffknecht, Christoph Gold, Sophia Brambs, Anouk Engel, Sven Stockhausen, Viktoria Knottenberg, Anna Titova, Mohamed Haji, Clemens Scherer, Maximilian Muenchhoff, Johannes C. Hellmuth, Kathrin Saar, Benjamin Schubert, Anne Hilgendorff, Christian Schulz, Stefan Kääb, Ralf Zimmer, Norbert Hübner, Steffen Massberg, Philipp Mertins, Leo Nicolai, Konstantin Stark
Title and authors | Publication | Year |
---|---|---|
Atypical response to bacterial co-infection and persistent neutrophilic broncho-alveolar inflammation distinguish critical COVID-19 from influenza
Seppe Cambier, Mieke Metzemaekers, Ana C. Carvalho, Amber Nooyens, Cato Jacobs, Lore Vanderbeke, Bert Malengier-Devlies, Mieke Gouwy, Elisabeth Heylen, Philippe Meersseman, Greet Hermans, Els Wauters, Alexander Wilmer, Contagious Consortium, Dominique Schols, Patrick Matthys, Ghislain Opdenakker, Rafael Elias Marques, Joost Wauters, Jennifer Vandooren, Paul Proost |
JCI Insight | 2022 |
Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19
Xinge Wang, Mark A Sanborn, Yang Dai, Jalees Rehman |
JCI Insight | 2022 |
Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19
S Li, F Zhao, J Ye, K Li, Q Wang, Z Du, Q Yue, S Wang, Q Wu, H Chen |
Medical Microbiology and Immunology | 2022 |
The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome
M Cesta, M Zippoli, C Marsiglia, E Gavioli, F Mantelli, M Allegretti, R Balk |
Frontiers in pharmacology | 2022 |
Evaluating the role of chemokines and chemokine receptors involved in coronavirus infection
G Olivarria, T Lane |
Expert Review of Clinical Immunology | 2022 |
NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond
Y Zhu, X Chen, X Liu |
Frontiers in immunology | 2022 |
Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure
E Gavriilidis, C Antoniadou, A Chrysanthopoulou, M Ntinopoulou, A Smyrlis, I Fotiadou, N Zioga, D Kogias, A Natsi, C Pelekoudas, E Satiridou, S Bakola, C Papagoras, I Mitroulis, P Peichamperis, D Mikroulis, V Papadopoulos, P Skendros, K Ritis |
Clinical Immunology | 2022 |
Neutrophil-Platelet Interactions as Novel Treatment Targets in Cardiovascular Disease
R Kaiser, R Escaig, J Erber, L Nicolai |
Frontiers in Cardiovascular Medicine | 2022 |
Immune Cell Plasticity in Inflammation: Insights into Description and Regulation of Immune Cell Phenotypes
Margraf A, Perretti M |
Cells | 2022 |
The relationship between peripheral immune response and disease severity in SARS‐CoV‐2‐infected subjects: A cross‐sectional study
Walter LO, Cardoso CC, Santos\u2010Pirath ÍM, Costa HZ, Gartner R, Werle I, Mohr ET, da Rosa JS, Felisberto M, Kretzer IF, Masukawa II, Vanny PD, Luiz MC, de Moraes AC, Dalmarco EM, Santos\u2010Silva MC |
Immunology | 2022 |
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Li X, Zhang Z, Wang Z, Gutiérrez-Castrellón P, Shi H |
Signal Transduction and Targeted Therapy | 2022 |
Complement activation in COVID-19 and targeted therapeutic options: A scoping review
Lim EH, van Amstel RB, de Boer VV, van Vught LA, de Bruin S, Brouwer MC, Vlaar AP, van de Beek D |
Blood Reviews | 2022 |
Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets
Russo A, Morrone HL, Rotundo S, Trecarichi EM, Torti C |
Diagnostics | 2022 |
The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials
Landoni G, Zangrillo A, Piersanti G, Scquizzato T, Piemonti L |
Frontiers in immunology | 2022 |
Neutrophils: Musketeers against immunotherapy.
Zahid KR, Raza U, Tumbath S, Jiang L, Xu W, Huang X |
Frontiers in Oncology | 2022 |
Resveratrol Downmodulates Neutrophil Extracellular Trap (NET) Generation by Neutrophils in Patients with Severe COVID-19
de Souza Andrade MM, Leal VN, Fernandes IG, Gozzi-Silva SC, Beserra DR, Oliveira EA, Teixeira FM, Yendo TM, Sousa MD, Teodoro WR, Oliveira LD, Alberca RW, Aoki V, Duarte AJ, Sato MN |
Antioxidants | 2022 |
Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review
Gianni P, Goldin M, Ngu S, Zafeiropoulos S, Geropoulos G, Giannis D |
World Journal of Experimental Medicine | 2022 |
SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling
Li TW, Kenney AD, Park JG, Fiches GN, Liu H, Zhou D, Biswas A, Zhao W, Que J, Santoso N, Martinez-Sobrido L, Yount JS, Zhu J |
Frontiers in immunology | 2022 |
Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients.
Bauer A, Pachl E, Hellmuth JC, Kneidinger N, Heydarian M, Frankenberger M, Stubbe HC, Ryffel B, Petrera A, Hauck SM, Behr J, Kaiser R, Scherer C, Deng L, Teupser D, Ahmidi N, Muenchhoff M, Schubert B, Hilgendorff A |
2022 | |
Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b.
García-García T, Fernández-Rodríguez R, Redondo N, de Lucas-Rius A, Zaldívar-López S, López-Ayllón BD, Suárez-Cárdenas JM, Jiménez-Marín Á, Montoya M, Garrido JJ |
iScience | 2022 |
Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts
Braun SA, Bauer AT, Németh C, Rózsa A, Rusch L, Erpenbeck L, Schloer S, Silling S, Metze D, Gerber PA, Schneider SW, Gyulai R, Homey B |
International journal of molecular sciences | 2022 |
Identification of hospitalized mortality of patients with COVID-19 by machine learning models based on blood inflammatory cytokines
Yu Z, Li X, Zhao J, Sun S |
Frontiers in public health | 2022 |
Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19
Rice CM, Lewis P, Ponce-Garcia FM, Gibbs W, Groves S, Cela D, Hamilton F, Arnold D, Hyams C, Oliver E, Barr R, Goenka A, Davidson A, Wooldridge L, Finn A, Rivino L, Amulic B |
Life science alliance | 2022 |
Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival
Cao JF, Gong Y, Wu M, Xiong L, Chen S, Huang H, Zhou X, Peng YC, Shen XF, Qu J, Wang YL, Zhang X |
Frontiers in Cellular and Infection Microbiology | 2022 |
Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes
Wu J, Zhang F, Zheng X, Zhang J, Cao P, Sun Z, Wang W |
Frontiers in immunology | 2022 |
Proteomic profiling of end-stage COVID-19 lung biopsies
Gindlhuber J, Tomin T, Wiesenhofer F, Zacharias M, Liesinger L, Demichev V, Kratochwill K, Gorkiewicz G, Schittmayer M, Birner-Gruenberger R |
Clinical Proteomics | 2022 |
Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines
Zhu W, Zhang Y, Wang Y |
Frontiers in pharmacology | 2022 |
Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Cremonesi G, Khan A, Mantelli F, Allegretti M, Balk R |
European Journal of Immunology | 2022 |